GlassScriptPhysician profile
Gregory S Taylor
NPI 1932113743
$4,665.67
in general payments reported to CMS, 2019-2025
34 companies · $19.67 in 2025
The $19.67 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $281 · 2021: $601 · 2022: $833 · 2023: $1,986 · 2024: $616 · 2025: $19.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,324 · Travel and Lodging: $1,212 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,324.36 |
| Travel and Lodging | $1,212.04 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,756.02 | 2019-2024 | Moses 550 D\F\L, Lithovue, Rezum Generator |
| Astellas Pharma US INC | $429.20 | 2019-2024 | Xtandi |
| Janssen Biotech, INC. | $326.75 | 2019-2024 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $283.47 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $168.80 | 2019-2024 | |
| Urovant Sciences INC | $164.37 | 2022 | |
| 180 Medical, INC. | $164.00 | 2019-2023 | |
| Abbvie INC. | $162.69 | 2022-2024 | Botox |
| Endo Pharmaceuticals INC. | $152.29 | 2019-2023 | Xiaflex |
| Dendreon Pharmaceuticals LLC | $124.71 | 2019-2022 | |
| Axonics, INC. | $110.66 | 2021-2024 | Bulkamid, Axonics |
| Myovant Sciences INC. | $99.33 | 2021-2022 | |
| Amgen INC. | $90.76 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $74.91 | 2020-2022 | |
| Teleflex LLC | $70.59 | 2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $70.09 | 2021 | |
| Tolmar, INC. | $46.12 | 2023 | |
| Myriad Genetic Laboratories, INC. | $37.68 | 2021 | |
| Coloplast Corp | $37.57 | 2024 | |
| Abc Home Medical Supply, INC. | $30.30 | 2024 | |
| Procept Biorobotics Corporation | $26.22 | 2024 | Aquabeam System |
| Allergan, INC. | $26.13 | 2019-2021 | |
| Hitachi Healthcare Americas Corp. | $26.03 | 2019 | |
| Profound Medical Corp. | $23.35 | 2022 | |
| Endo USA, INC. | $22.67 | 2024 | Xiaflex |
| Halozyme INC | $20.48 | 2023 | |
| Ferring Pharmaceuticals INC. | $20.00 | 2024 | Adstiladrin |
| Urogen Pharma, INC. | $16.13 | 2022 | |
| Merck Sharp & Dohme LLC | $15.68 | 2020 | |
| Cook Medical LLC | $15.63 | 2024 | Flexi-Tip |
| Neotract INC. | $15.24 | 2020 | |
| Travere Therapeutics, INC. | $15.12 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.39 | 2021 | |
| Baudax Bio INC. | $11.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.